If an application filed pursuant to section
355 of this title is approved for a drug designated under section
360bb of this title for a rare disease or condition or if a license is issued under section
262 of title
42 for such a drug, the Secretary may, during the seven-year period beginning on the date of the application approval or of the issuance of the license, approve another application under section
355 of this title or issue a license under section
262 of title
42, for such drug for such disease or condition for a person who is not the holder of such approved application or of such license if—